Published in Blood Weekly, July 7th, 2005
"The blood levels of the soluble forms of the urokinase receptor (suPAR) are increased in human immunodeficiency virus (HIV)-1-infected patients. This study investigated whether the release of urokinase-type plasminogen activator receptor (uPAR) in whole-blood cultures was affected by HIV infection," scientists writing in the Scandinavian Journal of Immunology report.
"The release of different uPAR forms in whole-blood cultures incubated 24 hours with or without phytohemagglutinin and lipopolysaccharide was analyzed in 47 HIV patients and 19...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Blood Weekly
Source: Blood Weekly (2005-07-07)
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.